Biotechnology Stocks I Performance Guide: Bicara Therapeutics Inc. (BCAX)
BCAX has no dividends.
Table and Chart of BCAX Performance
See what a $1,000 investment in BCAX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BCAX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -58299000 |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $None |
| 52 Week Low | $27.94 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $18 |
| 200-Day Moving Average | $25.24 |
| FINANCIAL DATA | |
| Revenue per Share | $-3.75 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | 0% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BCAX Compare Returns with S&P 500
BCAX Trendline Chart
BCAX Moving Average Chart
BCAX Stock Return Map - See Patterns of Gains and Losses
BCAX Stock Returns/Purchase Dates